Genome-Wide and Follow-Up Studies Identify CEP68 Gene Variants Associated with Risk of Aspirin-Intolerant Asthma
暂无分享,去创建一个
H. Shin | S. Uh | H. Cheong | Choon-Sik Park | Sang-Heon Cho | J. Bae | Jeong-Hyun Kim | A. Jang | J. Choi | Jong Sook Park | Mi-kyeong Kim | B. Choi | Yong-Hoon Kim | B. Park | I. Choi | Yong‐Hoon Kim
[1] D. Balding,et al. A Genome-Wide Association Study of the Metabolic Syndrome in Indian Asian Men , 2010, PloS one.
[2] D. Goldstein,et al. Uncovering the roles of rare variants in common disease through whole-genome sequencing , 2010, Nature Reviews Genetics.
[3] S. Uh,et al. Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics , 2009, Allergy, asthma & immunology research.
[4] Peter Kraft,et al. Genetic risk prediction--are we there yet? , 2009, The New England journal of medicine.
[5] D. Goldstein. Common genetic variation and human traits. , 2009, The New England journal of medicine.
[6] Yusuke Nakamura,et al. Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma. , 2009, The Journal of allergy and clinical immunology.
[7] J. Drazen,et al. Genetics and pharmacogenetics of the leukotriene pathway. , 2009, The Journal of allergy and clinical immunology.
[8] Y. Ye,et al. Combined effect of IL‐10 and TGF‐β1 promoter polymorphisms as a risk factor for aspirin‐intolerant asthma and rhinosinusitis , 2009, Allergy.
[9] I. Sayers,et al. Leukotriene pathway genetics and pharmacogenetics in allergy , 2009, Allergy.
[10] Ingo Ruczinski,et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. , 2009, American journal of human genetics.
[11] D. Postma,et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction , 2009, Nature Genetics.
[12] M. Daly,et al. Genetic Mapping in Human Disease , 2008, Science.
[13] I. Chung,et al. Association of angiotensin I‐converting enzyme gene polymorphisms with aspirin intolerance in asthmatics , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[14] Allen D. Roses,et al. Pharmacogenetics in drug discovery and development: a translational perspective , 2008, Nature Reviews Drug Discovery.
[15] Seung-Hyun Kim,et al. What do we know about the genetics of aspirin intolerance? , 2008, Journal of clinical pharmacy and therapeutics.
[16] Montgomery Slatkin,et al. Linkage disequilibrium — understanding the evolutionary past and mapping the medical future , 2008, Nature Reviews Genetics.
[17] E. Nigg,et al. Cep68 and Cep215 (Cdk5rap2) are required for centrosome cohesion , 2007, Journal of Cell Science.
[18] G. Hur,et al. CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients. , 2007, Pharmacogenomics.
[19] A. Penn,et al. In Utero Environmental Tobacco Smoke Exposure Alters Gene Expression in Lungs of Adult BALB/c Mice , 2007, Environmental health perspectives.
[20] Gonçalo R. Abecasis,et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma , 2007, Nature.
[21] B. Druker,et al. Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells , 2007, Proteomics.
[22] Y. Ye,et al. Association of TNF‐α genetic polymorphism with HLA DPB1*0301 , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[23] C. Suh,et al. Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin‐intolerant asthma in males , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[24] H. Shin,et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics , 2005, Pharmacogenetics and genomics.
[25] J. Holloway,et al. Polymorphism of tandem repeat in promoter of 5‐lipoxygenase in ASA‐intolerant asthma: a positive association with airway hyperresponsiveness , 2005, Allergy.
[26] S. Farooque,et al. Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[27] J. Holloway,et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid‐intolerant asthma , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[28] Yusuke Nakamura,et al. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma , 2005, Human Genetics.
[29] W. Smith,et al. Aspirin‐sensitive asthma , 2005, Internal medicine journal.
[30] R. Weinshilboum,et al. Pharmacogenomics: Bench to bedside. , 2005, Discovery medicine.
[31] M. Daly,et al. Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.
[32] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[33] T. Nakajima,et al. Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. , 2004, Human molecular genetics.
[34] Choon-Sik Park,et al. The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma. , 2004, The Journal of allergy and clinical immunology.
[35] A. Dhathathreyan,et al. Investigation of surface properties of amino acids: polarity scale for amino acids as a means to predict surface exposed residues in films of proteins. , 2004, Journal of colloid and interface science.
[36] Choon-Sik Park,et al. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. , 2004, The Journal of allergy and clinical immunology.
[37] H. Shin,et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase , 2004, Human Genetics.
[38] D. Stevenson,et al. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. , 2003, The Journal of allergy and clinical immunology.
[39] Masashi Kobayashi,et al. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. , 2002, The Journal of allergy and clinical immunology.
[40] R. Pauwels,et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.
[41] L. Wasserman,et al. Genomic control, a new approach to genetic-based association studies. , 2001, Theoretical population biology.
[42] A. Jeffreys,et al. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex , 2001, Nature Genetics.
[43] P. Donnelly,et al. A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.
[44] M. Sanak,et al. Leukotriene C4 synthase polymorphism and aspirin-induced asthma. , 2001, The Journal of allergy and clinical immunology.
[45] A. Leff. Regulation of leukotrienes in the management of asthma: biology and clinical therapy. , 2001, Annual review of medicine.
[46] S. Salvi,et al. Aspirin and asthma. , 2000, Chest.
[47] J. Drazen,et al. 5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. , 2000, The Journal of allergy and clinical immunology.
[48] E. Israel,et al. Treatment of asthma with drugs modifying the leukotriene pathway. , 1999, The New England journal of medicine.
[49] K. Pile,et al. Aspirin‐induced asthma and HLA‐DRB1 and HLA‐DPB1 genotypes , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[50] M. Kowalski. Aspirin sensitive rhinosinusitis and asthma. , 1995, Allergy proceedings : the official journal of regional and state allergy societies.
[51] P. Abrami,et al. Anaphylaxie et Idiosyncrasie , 1993 .
[52] P. Abrami,et al. Anaphylaxie et idiosyncrasie. 1992 [Anaphylaxis and idiosyncrasy. 1992]. , 1993, Allergy proceedings : the official journal of regional and state allergy societies.
[53] M. Kowalski. Management of aspirin-sensitive rhinosinusitis-asthma syndrome: what role for aspirin desensitization? , 1992, Allergy proceedings : the official journal of regional and state allergy societies.
[54] P. Hedrick,et al. Gametic disequilibrium measures: proceed with caution. , 1987, Genetics.